sign in sign up
<<
Home , Norpipanone

55588 Federal Register / Vol. 74, No. 207 / Wednesday, October 28, 2009 / Notices

Dated: October 16, 2009. Drug Schedule Drug Schedule Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of (9652) ...... II Meperidine (9230) ...... II Diversion Control, Drug Enforcement (9250) ...... II Administration. The company plans to manufacture Methadone intermediate (9254) ... II [FR Doc. E9–25895 Filed 10–27–09; 8:45 am] small quantities of the listed controlled (9300) ...... II (9333) ...... II BILLING CODE 4410–09–P substances to produce isotope labeled standards for drug testing and analysis. Oxymorphone (9652) ...... II Noroxymorphone (9668) ...... II Any other such applicant, and any (9737) ...... II DEPARTMENT OF JUSTICE person who is presently registered with (9739) ...... II DEA to manufacture such substances, (9740) ...... II Drug Enforcement Administration may file comments or objections to the (9801) ...... II issuance of the proposed registration Manufacturer of Controlled pursuant to 21 CFR 1301.33(a). The company plans to manufacture Substances; Notice of Application Any such written comments or the listed controlled substances in bulk Pursuant to § 1301.33(a) of Title 21 of objections should be addressed, in for sale to its customers. the Code of Federal Regulations (CFR), quintuplicate, to the Drug Enforcement Any other such applicant and any this is notice that on April 9, 2009, Administration, Office of Diversion person who is presently registered with Aldrich Chemical Company Inc., DBA Control, Federal Register Representative DEA to manufacture such a controlled Isotec, 3858 Benner Road, Miamisburg, (ODL), 8701 Morrissette Drive, substance may file comments or Ohio 45342–4304, made application by Springfield, Virginia 22152; and must be objections to the issuance of the renewal to the Drug Enforcement filed no later than December 28, 2009. proposed registration pursuant to 21 Administration (DEA) as a bulk Dated: October 20, 2009. CFR 1301.33(a). manufacturer of the basic classes of Joseph T. Rannazzisi, Any such written comments or objections should be addressed, in controlled substances listed in Deputy Assistant Administrator, Office of schedules I and II: Diversion Control, Drug Enforcement quintuplicate, to the Drug Enforcement Administration. Administration, Office of Diversion Drug Schedule [FR Doc. E9–25893 Filed 10–27–09; 8:45 am] Control, Federal Register Representative (ODL), 8701 Morrissette Drive, BILLING CODE 4410–09–M Gamma Hydroxybutyric Acid I Springfield, Virginia 22152; and must be (2010). filed no later than December 28, 2009. Methaqualone (2565) ...... I (7260) ...... I DEPARTMENT OF JUSTICE Dated: October 21, 2009. (7370) ..... I Joseph T. Rannazzisi, Drug Enforcement Administration 2,5-Dimethoxyamphetamine I Deputy Assistant Administrator, Office of (7396). Manufacturer of Controlled Diversion Control, Drug Enforcement Psilocyn (7438) ...... I Administration. Normorphine (9313) ...... I Substances; Notice of Application [FR Doc. E9–26002 Filed 10–27–09; 8:45 am] (9601) ...... I except levo- I Pursuant to § 1301.33(a) of Title 21 of BILLING CODE 4410–09–P alphacetylmethadol (9603). the Code of Federal Regulations (CFR), (9635) ...... I this is notice that on September 10, Norpipanone (9636) ...... I 2009, Johnson Matthey Inc., Custom DEPARTMENT OF JUSTICE 3-Methylfentanyl (9813) ...... I Pharmaceuticals Department, 2003 Amphetamine (1100) ...... II Nolte Drive, West Deptford, New Jersey Drug Enforcement Administration Methamphetamine (1105) ...... II 08066–1742, made application by Methylphenidate (1724) ...... II Manufacturer of Controlled renewal to the Drug Enforcement Amobarbital (2125) ...... II Substances; Notice of Registration Pentobarbital (2270) ...... II Administration (DEA) to be registered as Secobarbital (2315) ...... II a bulk manufacturer of the basic classes By Notice dated June 15, 2009, and 1-Phenylcyclohexylamine (7460) II of controlled substances listed in published in the Federal Register on (7471) ...... II schedules I and II: June 23, 2009, (74 FR 29720), Noramco Phenylacetone (8501) ...... II Inc., Division of Ortho-McNeil, Inc., 1-Piperidinocyclohexane- II Drug Schedule 1440 Olympic Drive, Athens, Georgia carbonitrile (8603). 30601, made application by letter to the (9041) ...... II Gamma Hydroxybutyric Acid I Drug Enforcement Administration (9050) ...... II (2010). (9143) ...... II Tetrahydrocannabinols (7370) ..... I (DEA) to be registered as a bulk (9150) ...... II (9145) ...... I manufacturer of Noroxymorphone Benzoylecgonine (9180) ...... II Difenoxin (9168) ...... I (9668), a basic class of controlled (9190) ...... II (9649) ...... I substance listed in schedule II. (9193) ...... II Amphetamine (1100) ...... II The company plans to bulk (9226) ...... II Methamphetamine (1105) ...... II manufacture the above listed controlled Meperidine (9230) ...... II Lisdexamfetamine (1205) ...... II substance for distribution to its Meperidine intermediate-A (9232) II Methylphenidate (1724) ...... II customers. Meperidine intermediate-B (9233) II (7379) ...... II No comments or objections have been Cocaine (9041) ...... II Methadone (9250) ...... II received. DEA has considered the Methadone intermediate (9254) ... II Codeine (9050) ...... II , bulk, (non- II (9120) ...... II factors in 21 U.S.C 823(a) and dosage forms) (9273). Oxycodone (9143) ...... II determined that the registration of Morphine (9300) ...... II Hydromorphone (9150) ...... II Noramco, Inc. to manufacture the listed Thebaine (9333) ...... II Ecgonine (9180) ...... II basic class of controlled substance is Levo-alphacetylmethadol (9648) .. II Hydrocodone (9193) ...... II consistent with the public interest at

VerDate Nov<24>2008 15:34 Oct 27, 2009 Jkt 220001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\28OCN1.SGM 28OCN1 erowe on DSK5CLS3C1PROD with NOTICES